Janssen Closer To End-To-End R&D Model With New Research Center In Shanghai
This article was originally published in PharmAsia News
Executive Summary
Janssen has placed a further bet on China R&D by establishing a pharmaceutical discovery laboratory in Shanghai’s Fenglin Life Science Park.